SMI
13.003,33
PKT
-132,94
PKT
-1,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.10.12 | Swisscom neutral | Nomura | |
| 11.10.12 | Nestlé overweight | Morgan Stanley | |
| 11.10.12 | Kühne + Nagel International hold | Vontobel Research | |
| 10.10.12 | UBS overweight | J.P. Morgan Cazenove | |
| 10.10.12 | Nestlé neutral | UBS AG | |
| 10.10.12 | Richemont neutral | Credit Suisse Group | |
| 10.10.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
| 10.10.12 | Givaudan equal-weight | Morgan Stanley | |
| 10.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 09.10.12 | Givaudan reduce | Nomura | |
| 09.10.12 | ABB (Asea Brown Boveri) underperform | Cheuvreux SA | |
| 09.10.12 | Kühne + Nagel International buy | Nomura | |
| 09.10.12 | Givaudan neutral | Sarasin Research | |
| 09.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Holcim outperform | Sanford C. Bernstein and Co., Inc. | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 08.10.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 08.10.12 | Novartis reduce | Vontobel Research | |
| 05.10.12 | Givaudan neutral | UBS AG | |
| 05.10.12 | Lonza hold | Vontobel Research | |
| 05.10.12 | Swiss Re neutral | Sarasin Research | |
| 04.10.12 | Novartis buy | Nomura | |
| 04.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 04.10.12 | Givaudan neutral | Credit Suisse Group | |
| 04.10.12 | Nestlé neutral | Citigroup Corp. | |
| 04.10.12 | Swiss Re buy | Vontobel Research | |
| 03.10.12 | UBS overweight | HSBC | |
| 02.10.12 | Holcim hold | Deutsche Bank AG | |
| 02.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 02.10.12 | Nestlé buy | Sarasin Research | |
| 02.10.12 | Richemont buy | Vontobel Research | |
| 01.10.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 01.10.12 | Holcim underperform | Cheuvreux SA | |
| 01.10.12 | Novartis buy | Sarasin Research | |
| 01.10.12 | Novartis reduce | Vontobel Research | |
| 01.10.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 28.09.12 | Nestlé overweight | J.P. Morgan Cazenove | |
| 28.09.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 28.09.12 | Holcim outperform | Exane-BNP Paribas SA |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.